ClinicalTrials.gov
public full text
Public Domain
The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
To test the effect of Nexium and probiotics on insulin secretion and cardiovascular risk factors on type 2 diabetic patients. Study Hypothesis: 1. Nexium causes an increased gastrin secretion that increases the insulin secretion and thereby a reduction of HbA1c 2. Probiotics changes the gut flora and bloodpressure 3. Probiotics causes a change in inflammation and thrombosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Personalized Medicine for Diabetes Prediction and Prevention of Complications#1094575
- Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)#1164512
- Effect of Probiotics on Blood Pressure Management#838457
- Probiotics and Systemic Inflammation in Patients With Metabolic Syndrome and High Cardiovascular Risk#303545
- Nutrigenetic Intervention on Blood Lipid Markers and Body Composition of Adults With Overweight and Obesity#811843
Record · ID 894737
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive